Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 USD | +1.53% | +4.19% | 0.00% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 34.05M | |
+23.43% | 86.96B | |
-23.66% | 75.65B | |
+0.49% | 26.97B | |
+5.59% | 17.89B | |
-13.22% | 16.58B | |
+3.12% | 15.73B | |
+75.86% | 13.01B | |
+79.03% | 12.92B | |
+37.66% | 12.57B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen : Prices Common Stock Offering at $16.25 Per Share